The concentration of CD26-positive CML LSCs in blood and bone marrow reportedly correlates with the white blood cells (WBC), but a relationship with response to TKI-therapy is unproved [29, 36]. Here, DPP4 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.